Founded in 2019, Veragrow uses a proprietary extraction and stabilization process to isolate active compounds generated by more than 25 million earthworms converting agricultural co-products into high-value lombricompost. The resulting plant-based biostimulant formulations have demonstrated strong agronomic performance in over 930 field trials across crops such as wheat, maize, potatoes, sugar beet, oilseed rape, flax, vineyards, and vegetables. By 2025 the company had built a distribution network of 30+ partners in France and initiated field trials in more than 20 countries, including Denmark, Morocco, Brazil, and Senegal. Operating from an integrated R&D, production, and commercialization hub in Val-de-Reuil, Veragrow collaborates with institutions like INRAE, CNRS, UniLaSalle, and GlycoMev. The new capital injection will fund expansion of production capacity, reinforcement of its sales network, and acceleration of R&D, with six additional formulations slated for launch in 2026. Veragrow aims to become a leading global manufacturer of bio-based biostimulants by 2030.

Total raised

$6M

Funding rounds

2

Latest round

Equity

Latest activity

Dec 2025